Alexion Pharmaceuticals

352 Knotter Drive
Cheshire,  CT  06410

United States
Phone: 203-272-2595
Fax: 203-272-2595
  • Booth: 311


Alexion Pharmaceuticals, Inc. is a biopharmaceutical company focused on serving patients with ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. It developed and markets Soliris® as a treatment for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Alexion is developing other innovative product candidates, including asfotase alfa, an enzyme replacement therapy for patients with hypophosphatasia (HPP), an ultra-rare, genetic, life-threatening metabolic disease.

Registration for ACMG 2017

Register will open in October 2016

March 21 - 25, 2017
Phoenix Convention Center
Phoenix, Arizona

Hotel Reservations

Reserve your room early to get the best choice.